Dr. Reddy(RDY) - 2023 Q4 - Annual Report

Company Information and Regulatory Context Dr. Reddy's Laboratories Ltd. provides regulatory intimation regarding upcoming analyst and institutional investor meetings Purpose of Intimation Dr. Reddy's Laboratories Ltd. informs stock exchanges of upcoming analyst and investor meetings under SEBI Regulation 30 - Dr. Reddy's Laboratories Ltd. provides intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015[1] - The intimation concerns the schedule of upcoming Analyst / Institutional Investor Meetings[1] Schedule of Analyst / Institutional Investor Meetings The company's upcoming analyst and institutional investor meetings are detailed with dates, organizers, and formats Meeting Details Management will attend four investor events from June 13-20, 2023, including a global healthcare conference and group meetings Meeting details table | Date | Organized by | Meeting details | Location | Timing | |---|---|---|---|---| | 13-Jun-23 | Goldman Sachs | 44th Annual Global Healthcare Conference | California, US | 08:40 to 17:15 hrs PDT (from 9:10 pm IST) | | 15-Jun-23 | BofA Securities | Investor group meeting | Virtual | 16:00 to 17:00 hrs IST | | 19-Jun-23 | Kotak Securities | Investor group meeting | Hyderabad | 10:00 to 11:00 hrs IST 14:00 to 17:00 hrs IST | | 20-Jun-23 | JM Financial Institutional Securities | Investor group meeting | Hyderabad | 10:00 to 11:30 hrs IST | Important Notes and Formalities Disclaimers on meeting schedule changes and formal signatory and distribution details for the intimation are provided Disclaimer on Schedule Changes Meeting schedules are provisional and subject to change due to exigencies from investors or the company - Meeting schedules are subject to change due to exigencies on the part of Investors / Company[1] Signatory and Distribution The intimation was formally submitted by K Randhir Singh, Company Secretary, and distributed to major stock exchanges - The intimation was signed by K Randhir Singh, Company Secretary, Compliance Officer, and Head CSR[2] - Copies were sent to New York Stock Exchange Inc. (Stock Code: RDY) and NSE IFSC Ltd, in addition to the primary recipients[2]